Vivos Therapeutics Inc (NAS:VVOS)
$ 3.1 0.25 (8.8%) Market Cap: 14.77 Mil Enterprise Value: 8.39 Mil PE Ratio: 0 PB Ratio: 1.52 GF Score: 65/100

Vivos Therapeutics Inc Annual Shareholders Meeting Transcript

Aug 25, 2022 / 08:00PM GMT
Release Date Price: $31.25 (+1.63%)
Kirk Huntsman
Vivos Therapeutics, Inc. - Chairman & CEO

Good afternoon. And on behalf of our Board of Directors and our officers and employees, I would like to welcome everyone to the 2022 annual meeting of stockholders of Vivos Therapeutics, which is being held live via live webcast. I am Kirk Huntsman, Chief Executive Officer and Chairman of the Board of Directors of the Vivos. I will act as Chair of this meeting.

Here with me today is Brad Amman, our Chief Financial Officer, Secretary, and Treasurer, who will act as Secretary of the meeting and as the Inspector of Election. Also present today, in listen-only mode are the members of our Board of Directors as well as many of our employees and our outside legal counsel.

As we did last year, we are pleased to hold our annual meeting virtually via the internet. Virtual shareholder meetings are increasing in prevalence and allow for improved access and increased attendance. By hosting our meeting virtually, all of our shareholders are more easily able to attend.

All stockholders of record on July 5, 2022, are eligible to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot